RNS Number : 6412B Redcentric PLC 23 August 2024 Redcentric plc Director/PDMR Shareholdings Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, announces that on 23 August 2024 certain Directors of the Company and their persons closely associated ("PCA"), exercised options over, in aggregate, 109,802 ordinary shares of 0.1p in the Company ("Ordinary Shares") and subsequently sold this number of Ordinary Share as set out below: The Company is issuing 109,802 Ordinary Shares to satisfy the Exercise. Application has been made to the London Stock Exchange for these Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will be effective and dealings will commence in respect of the Ordinary Shares at 8.00 a.m. on or around 2 September 2024. Following Admission, the Company's issued share capital will consist of 159,006,988 Ordinary Shares, 618,188 of which remain held in Treasury. For reporting under the FCA's Disclosure Guidance and Transparency Rules, shareholders should exclude any Ordinary Shares held in Treasury and should use the figure of 158,388,800 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company. The notifications below, which have been made in accordance with the requirements of the Market Abuse Regulation, provide further detail. Enquiries: Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END DSHPJMJTMTTTBLI